+1-902-442-0653
Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street
Technology
Technology
Technology Overview
Therapies
Therapies Overview
Targeted Hyperthermia Therapy
Pre-Clinical Study
Whitepapers and Publications
The Giacomantonio Immuno-Oncology Research Group
THT Vaccine Effect
Diagnostics
Diagnostics Overview
Investors
Share Information
Investor Presentation
Financial Reports
News & Media
All News & Media
News Releases
Media Centre
Media Kit
About Us
Our Story
Leadership
Board of Directors
Advisory Board
Contact Us
Contact
Newsletter Subscribe
Store
Order
Your Account
Information
Shipping Information
Purchasing Information
Storage and Handling
0
Subscribe
Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues
October 29, 2020
News Releases
Previous Article
Is Canada focused on the wrong COVID-19 tests?
Next Article
Sona Nanotech appoints new Director
You may also like
Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Sona’s Therapy Shows Significant Preclinical Efficacy in Second Cancer
Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent
Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
Technology
Technology
Technology Overview
Therapies
Therapies Overview
Targeted Hyperthermia Therapy
Pre-Clinical Study
Whitepapers and Publications
The Giacomantonio Immuno-Oncology Research Group
THT Vaccine Effect
Diagnostics
Diagnostics Overview
Investors
Share Information
Investor Presentation
Financial Reports
News & Media
All News & Media
News Releases
Media Centre
Media Kit
About Us
Our Story
Leadership
Board of Directors
Advisory Board
Contact Us
Contact
Newsletter Subscribe
Store
Order
Your Account
Information
Shipping Information
Purchasing Information
Storage and Handling
0
Subscribe